Geneza Pharmaceuticals GP Prima 100 Lab Test Results

Introduction

Geneza Pharmaceuticals GP Prima 100 is presented in a 10-milliliter multidose vial, labeled to contain 100 milligrams of methenolone enanthate per milliliter. As part of its ongoing commitment to harm reduction, AnabolicLab procured samples of this product from a European-based internet source to independently verify its label claims and evaluate its quality. The samples were purchased between August 1, 2016, and September 15, 2016, and were submitted to SIMEC AG, an independent, internationally accredited analytical laboratory, for comprehensive testing.

AnabolicLab funded the analysis, which included HPLC-UV quantitative dosage testing and microbiological testing to ensure both the accuracy of the stated dosage and the product’s safety. These findings are published exclusively for educational and harm reduction purposes, empowering consumers with reliable and transparent information about the quality of anabolic steroids on the market.

Testing Results and Authentication

The samples were received by SIMEC AG on September 29, 2016, and the report was finalized on November 17, 2016.

Product Overview

Manufacturer: Geneza Pharmaceuticals
Product Name: GP Prima 100
Active Ingredient: Methenolone Enanthate
Lot Number: GP138CN
ISN Number: A4N6814M92DP (successfully verified on genezapharmaceuticals.com)
Expiration Date: March 2018
Delivery Method: Injectable (10-milliliter multidose vial)
Specification: 100 mg/ml methenolone enanthate

Sample Acquisition and Testing

Date Purchased: Between August 1, 2016, and September 15, 2016
Source: European-based internet supplier
Product Submitted By: AnabolicLab
Analysis Paid For By: AnabolicLab
Analysis Performed By: SIMEC AG
Date Received by Lab: September 29, 2016
Date Report Completed: November 17, 2016

Testing Results

Quantitative Dosage Testing (HPLC-UV):

Claimed Dosage: 100 mg/ml methenolone enanthate
Measured Dosage: 96.4 mg/ml methenolone enanthate
Accuracy: 96.4% (slightly below the label claim)
Variance: -3.6% (measured dosage was 3.6% below the label claim)

Microbiological Contamination Testing:

Total Aerobial Microbiological Count (TAMC): No contamination detected
Total Yeast and Mold Count (TYMC): No contamination detected

Summary

The analysis of Geneza Pharmaceuticals GP Prima 100 confirmed its authenticity and indicated a measured concentration of 96.4 mg/ml methenolone enanthate, which was 3.6% below the label claim but still within a generally acceptable range for accuracy. The ISN verification further validated the product’s legitimacy. Microbiological testing detected no contamination, ensuring the product’s safety for use. By publishing these findings, AnabolicLab reinforces transparency in the anabolic steroid market and provides consumers with reliable, independently verified information.

Commitment to Harm Reduction

AnabolicLab’s harm reduction mission focuses on promoting transparency and safety in the anabolic steroid market through independent analysis. By publishing accurate, unbiased results, AnabolicLab empowers consumers to make informed decisions and fosters accountability among manufacturers.

Disclaimer
The information provided here is for educational and harm reduction purposes only. AnabolicLab does not endorse or promote the use of anabolic steroids or other controlled substances.

Discuss the Geneza Pharmaceuticals GP Prima 100 lab test results on the AnabolicLab Forum.

(The following images are photographs of the actual product that was submitted for testing.)

Geneza Pharma GP Prima 100 Dosage Quantification Lab Results [PDF]
Does Geneza Pharma GP Prima 100 contain 100 milligrams of methenolone enanthate in each milliliter of solution? HPLC-UV, TAMC, TYMC (November 17, 2016) …

Size	2.52 MB
Downloaded	748 times
Last Updated	November 21, 2016
Download